31 related articles for article (PubMed ID: 6191141)
1. Plasma lipid fractions during long-term monotherapy with the ISA-containing beta-adrenoceptor blocker bopindolol in hypertensive patients.
Van Brummelen P; Bolli P; Koolen MI; Staehelin HB; Bühler FR
Br J Clin Pharmacol; 1984 Jan; 17(1):86-8. PubMed ID: 6691892
[TBL] [Abstract][Full Text] [Related]
2. Haemodynamic effects of short-term treatment with bopindolol in essential hypertension.
Fitscha P; Meisner W; Brandstetter G; Tiso B
Eur J Clin Pharmacol; 1988; 34(4):411-3. PubMed ID: 2900146
[TBL] [Abstract][Full Text] [Related]
3. Bopindolol, pindolol, and atenolol in patients with chronic obstructive lung disease.
Dorow P; Schiess W
Klin Wochenschr; 1986 Apr; 64(8):366-9. PubMed ID: 2871220
[TBL] [Abstract][Full Text] [Related]
4. Pharmacological experiments in healthy volunteers with bopindolol, a long-acting beta-adrenoceptor blocking drug with partial agonist activity.
Aellig WH
Br J Clin Pharmacol; 1985 Jun; 19(6):775-81. PubMed ID: 2862891
[TBL] [Abstract][Full Text] [Related]
5. Steady state pharmacokinetics of hydrolysed bopindolol in young and elderly men.
Holmes D; Nuesch E; Houle JM; Rosenthaler J
Eur J Clin Pharmacol; 1991; 41(2):175-8. PubMed ID: 1683836
[TBL] [Abstract][Full Text] [Related]
6. Bopindolol. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy.
Harron DW; Goa KL; Langtry HD
Drugs; 1991 Jan; 41(1):130-49. PubMed ID: 1706984
[TBL] [Abstract][Full Text] [Related]
7. Blood pressure lowering efficacy of dual alpha and beta blockers for primary hypertension.
Wong GW; Laugerotte A; Wright JM
Cochrane Database Syst Rev; 2015 Aug; 2015(8):CD007449. PubMed ID: 26306578
[TBL] [Abstract][Full Text] [Related]
8. Effects of a new long-acting beta-blocker bopindolol (LT 31-200) on blood pressure, plasma catecholamines, renin and cholesterol in patients with arterial hypertension.
van Brummelen P; Bühler FR; Amann FW; Bolli P
Eur J Clin Pharmacol; 1982; 22(6):491-3. PubMed ID: 6127218
[TBL] [Abstract][Full Text] [Related]
9. Antihypertensive treatment with bopindolol alone or combined with a diuretic in general practice.
Weidmann P; Bousquet JC
J Cardiovasc Pharmacol; 1986; 8 Suppl 6():S80-7. PubMed ID: 2439828
[TBL] [Abstract][Full Text] [Related]
10. Double-blind comparison of once-daily bopindolol, pindolol and atenolol in essential hypertension.
Schiess W; Welzel D; Gugler R
Eur J Clin Pharmacol; 1984; 27(5):529-34. PubMed ID: 6151506
[TBL] [Abstract][Full Text] [Related]
11. Dose-finding study with bopindolol in arterial hypertension.
Willimann P; Peter R; Siegenthaler H
J Cardiovasc Pharmacol; 1986; 8 Suppl 6():S25-9. PubMed ID: 2439814
[TBL] [Abstract][Full Text] [Related]
12. Antihypertensive effect of bopindolol: a multi-centre study.
Török E; Szám I; Buday G; Kerkovits G; Farsang C; Hajtman B
J Hum Hypertens; 1990 Aug; 4(4):458-60. PubMed ID: 1979635
[TBL] [Abstract][Full Text] [Related]
13. Antihypertensive efficacy of the new long-acting beta-blocker bopindolol as related to age.
Hulthén UL; van Brummelen P; Amann FW; Bühler FR
J Cardiovasc Pharmacol; 1983; 5(3):426-9. PubMed ID: 6191141
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
